Silverback Therapeutics


Data by 
Silverback Therapeutics is a biopharmaceutical company that develops ImmunoTAC therapies targeting previously inaccessible disease pathways.
Rankings by

National Ranking1609th
in United States Regional Ranking1727th
in North America Global Ranking3532nd
worldwide